checkAd
    Startseite > Aktien > MindBio Therapeutics > Nachrichten
    MindBio Therapeutics Aktie
    0,0550
     
    CAD
    -8,33 %
    -0,0050 CAD
    Letzter Kurs 03.05.24 CSE
    0,0500
     
    CAD
    60.000 STK
    Geldkurs 03.05.24
    0,0700
     
    CAD
    1.000 STK
    Briefkurs 03.05.24
    ISIN: CA60256C1086 · WKN: A3EB9V · SYM: MBIO · Kanada

    Neueste Nachrichten

    MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
    02.05.24 · Accesswire · MindBio Therapeutics
    MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3
    01.05.24 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
    30.04.24 · Accesswire · MindBio Therapeutics
    MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
    23.04.24 · Accesswire · MindBio Therapeutics
    Lender Requests to Convert Loan to MindBio Shares
    16.04.24 · Accesswire · MindBio Therapeutics
    MindBio Begins Landmark Phase 2B Take-Home Microdosing (MB22001) Clinical Trial in Patients with Major Depressive Disorder
    20.03.24 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder
    04.03.24 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics Announces Positive Depression Data from World-First Phase 2a Take-Home Microdosing Trial
    26.02.24 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
    20.12.23 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics Team Members Honoured with Industry Leading Awards
    21.11.23 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
    31.10.23 · Accesswire · MindBio Therapeutics
    MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
    29.10.23 · Accesswire · MindBio Therapeutics